CSIMarket



Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's EPS Net Growth by Quarter and Year

Merck And Co Inc 's EPS Net results by quarter and year




MRK EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1.48 -0.83 0.92
III Quarter September - 1.80 1.16 0.74
II Quarter June - 0.61 1.18 1.03
I Quarter March 1.70 1.25 1.26 1.12
FY   1.70 5.14 2.77 3.81



MRK EPS Net first quarter 2022 Y/Y Growth Comment
Merck and Co Inc achieved in the first quarter 2022, above Company average EPS Net growth of 36% year on year, to $ 1.70 .

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 9 other companies have achieved higher EPS Net growth. While Merck And Co Inc ' s EPS Net rise of 36% ranks overall at the positon no. 446 in the first quarter 2022.




MRK EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - 31.43 %
III Quarter September - 55.17 % 56.76 % 1.37 %
II Quarter June - -48.31 % 14.56 % 63.49 %
I Quarter March 36 % -0.79 % 12.5 % 314.81 %
FY   - 85.56 % -27.3 % 63.52 %

Financial Statements
Merck And Co Inc 's first quarter 2022 EPS Net $ 1.70 MRK's Income Statement
Merck And Co Inc 's first quarter 2021 EPS Net $ 1.25 Quarterly MRK's Income Statement
New: More MRK's historic EPS Net Growth >>


MRK EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -17.78 % - 24.32 %
III Quarter September - 195.08 % -1.69 % -28.16 %
II Quarter June - -51.2 % -6.35 % -8.04 %
I Quarter March 14.86 % - 36.96 % 60 %
FY (Year on Year)   - 85.56 % -27.3 % 63.52 %




EPS Net first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #29
Overall #446

EPS Net Y/Y Growth Statistics
High Average Low
152.53 % 8.39 % -90.32 %
(Sep 30 2018)   (Dec. 30, 2010)
EPS Net first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #29
Overall #446
EPS Net Y/Y Growth Statistics
High Average Low
152.53 % 8.39 % -90.32 %
(Sep 30 2018)   (Dec. 30, 2010)

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merck And Co Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
719.35 % 27.83 % -96.17 %
IV. Quarter  


MRK's I. Quarter Q/Q EPS Net Comment
Merck and Co Inc achieved in the I. Quarter 2022 below company average EPS Net rise of 14.86% quarter on quarter, to $ 1.70 .

Even if the I. Quarter 2022 performance was below the regular of 27.83 %, that has been still good story, as the current surge, eclipses the % EPS Net rise in the same quarter a year ago

Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher EPS Net quarter on quarter growth. While Merck And Co Inc 's EPS Net growth quarter on quarter, overall rank is 448.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #25
Overall #448
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #25
Overall #448
EPS Net Q/Q Growth Statistics
High Average Low
719.35 % 27.83 % -96.17 %
IV. Quarter  


MRK's I. Quarter Q/Q EPS Net Comment
Merck and Co Inc achieved in the I. Quarter 2022 below company average EPS Net rise of 14.86% quarter on quarter, to $ 1.70 .

Albeit the I. Quarter 2022 Merck And Co Inc 's EPS Net Q/Q growth was below the average of 27.83 %, that was yet promising story, as the I. Quarter improvement, transcends the % EPS Net rise in the I. Quarter 2021

Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher EPS Net quarter on quarter growth. While Merck And Co Inc 's EPS Net growth quarter on quarter, overall rank is 448.


Merck And Co Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS Net 12 Months Ending $ 5.59 $ 5.14 $ 2.83 $ 2.19 $ 2.76
Y / Y EPS Net Growth (TTM) 102.12 % 85.18 % -37.24 % -46.43 % -29.95 %
Year on Year EPS Net Growth Overall Ranking # 251 # 316 # 1002 # 1602 # 637
Seqeuential EPS Net Change (TTM) 8.76 % 81.26 % 29.16 % -20.62 % -0.36 %
Seq. EPS Net Growth (TTM) Overall Ranking # 446 # 95 # 374 # 1935 # 646




Cumulative EPS Net growth Comment
Merck And Co Inc saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 102.12% year on year, to $ 6 if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months EPS Net growth was higher than company's average 40.66% and higher than 85.18% growth in Dec 31 2021.
But sequential increase was beneth at 8.76 % from $5.14 achieved in twelve months ending a quarter before.
Still this was confirmation of strength, as the average sequential growth stands at 8.39%.
The progress is even higher from twelve months ended Dec 31 2021 exhibited at 8.76 % rise from $5.14 in twelve months ending a quarter before.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 251, from total ranking in previous quarter at 316.

EPS Net TTM Q/Q Growth Statistics
High Average Low
152.53 %
8.39 %
-90.32 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 20
Overall # 251

EPS Net TTM Y/Y Growth Statistics
High Average Low
651.85 %
40.66 %
-94.97 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 29
S&P 500 # 446
Cumulative EPS Net growth Comment
Merck And Co Inc saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 102.12% year on year, to $ 6 if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months EPS Net growth was higher than company's average 40.66% and higher than 85.18% growth in Dec 31 2021.
But from twelve months ended Dec 31 2021 rise was less at 8.76 % from $5.14 achieved in twelve months ending a quarter Dec 31 2021 Evan  O. Hall went on.
In spite of, this was confirmation of strength, as the typical sequential growth is at 8.39%.
The growth was much higher sequentially clinched at 8.76 % jump from $5.14 in the period from Dec 31 2021 to Mar 31 2021.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 251, from total ranking in previous quarter at 316.

EPS Net TTM Q/Q Growth Statistics
High Average Low
152.53 %
8.39 %
-90.32 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 20
Overall # 251

EPS Net TTM Y/Y Growth Statistics
High Average Low
651.85 %
40.66 %
-94.97 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 29
S&P 500 # 446




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
MRK's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for MRK's Competitors
EPS Net Growth for Merck And Co Inc 's Suppliers
EPS Net Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar EPS Net rise for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2022
Becton Dickinson And Company59.57%$ 59.574 
Repligen Corp55.77%$ 55.769 
Iqvia Holdings Inc 54.13%$ 54.128 
Conmed Corporation51.61%$ 51.613 
Charles River Laboratories International inc 50.83%$ 50.833 
Medpace Holdings Inc 48.25%$ 48.246 
Phibro Animal Health Corp46.67%$ 46.667 
Abcellera Biologics Inc 45.95%$ 45.946 
Prestige Consumer Healthcare Inc 44.99%$ 44.992 
Tenet Healthcare Corp42.22%$ 42.222 
Eli Lilly And Company40.94%$ 40.940 
Abbott Laboratories37.00%$ 37.000 
Merck and Co Inc 36.00%$ 36.000 
Bio techne Corp32.14%$ 32.143 
Co diagnostics Inc 30.77%$ 30.769 
Abbvie Inc 26.13%$ 26.131 
Mettler Toledo International Inc19.46%$ 19.462 
Syneos Health Inc 18.92%$ 18.919 
Vertex Pharmaceuticals Inc18.88%$ 18.876 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RDWR's Profile

Stock Price

RDWR's Financials

Business Description

Fundamentals

Charts & Quotes

RDWR's News

Suppliers

RDWR's Competitors

Customers & Markets

Economic Indicators

RDWR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071